Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157: H7 and non-O157 biofilms

Toxicology in Vitro

Volumn 29, Issue 7, 2015, Pages 1692-1700

  Angel Villegas, Natalia ^a   Baronetti, José ^a   Albesa, Inés ^a   Etcheverría, Analía ^b   Becerra, M Cecilia ^a   Padola, Nora L ^b   Paraje, M Gabriela ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

Antibiotic; Biofilms; Ciprofloxacin; Escherichia coli O157:H7; Fosfomycin; Hemolytic uremic syndrome (HUS); Rifaximin; Shiga toxin (Stx)

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CIPROFLOXACIN; FOSFOMYCIN; GLUTATHIONE; NITRITE; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; RIFAXIMIN; SHIGA TOXIN; SUPEROXIDE DISMUTASE; TIRON; ANTIINFECTIVE AGENT; NITRIC OXIDE; RIFAMYCIN; VEROTOXIN 1; VEROTOXIN 2; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; CELL STRESS; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; ESCHERICHIA COLI O157; METABOLITE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; VERO CELL LINE; ANIMAL; CELL SURVIVAL; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; ASCORBIC ACID; BIOFILMS; CATALASE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CIPROFLOXACIN; FOSFOMYCIN; GLUTATHIONE; MICROBIAL SENSITIVITY TESTS; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RIFAMYCINS; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; SUPEROXIDE DISMUTASE; VERO CELLS; VIRULENCE FACTORS;

EID: 84936878399     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.06.025     Document Type: Article

References (59)

1. Abu-Ali G.S., Ouellette L.M., Henderson S.T., Lacher D.W., Riordan J.T., et al. Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections. PLoS ONE 2010, 5:10167.
2. Aiassa V., Barnes A.I., Smania A.M., Albesa I. Sublethal ciprofloxacin treatment leads to resistance via antioxidant systems in Proteus mirabilis. FEMS Microbiol. Lett. 2012, 327:25-32.
3. Al Safadi R., Abu-Ali G.S., Sloup R.E., Rudrik J.T., Waters C.M., Eaton K.A., Manning S.D. Correlation between in vivo biofilm formation and virulence gene expression in Escherichia coli O104:H4. PLoS One 2012, 7:41628.
4. Albesa I., Becerra M.C., Battán P.C., Páez P.L. Oxidative stress involved in the antibacterial action of different antibiotics. Biochem. Biophys. Res. Commun. 2004, 317:605-609.
5. Angel Villegas N., Baronetti J., Albesa I., Polifroni R., Parma A., Etcheverría A., Becerra M., Padola N., Paraje M. Relevance of biofilms in the pathogenesis of Shiga-Toxin-producing Escherichia coli, infection. Sci. World J. 2013, 12:607258.
6. Arce Miranda J.E., Sotomayor C.E., Albesa I., Paraje M.G. Oxidative and nitrosative stress in Staphylococcus aureus biofilm. FEMS Microbiol. Lett. 2011, 1:23-29.
7. Baronetti J.L., Angel Villegas N., Paraje M.G., Albesa I. Nitric oxide-mediated apoptosis in rat macrophages subjected to Shiga toxin 2 from Escherichia coli. Microbiol. Immunol. 2011, 55:231-238.
8. Baronetti J.L., Angel Villegas N., Aiassa V., Paraje M.G., Albesa I. Hemolysin from Escherichia coli induces oxidative stress in blood. Toxicon 2013, 70:15-20.
9. Barraud N., Hassett D.J., Hwang S.H., Rice S.A., Kjelleberg S., Webb J.S. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J. Bacteriol. 2006, 188:7344-7353.
10. Bergan J., Dyve Lingelem A.B., Simm R., Skotland T., Sandvig K. Shiga toxins. Toxicon 2012, 60:1085-1107.
11. Bielaszewska M., Mellmann A., Zhang W., Köck R., Fruth A., Bauwens A., Peters G., Karch H. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 2011, 1:671-676.
12. Bielaszewska M., Idelevich E.A., Zhang W., Bauwens A., Schaumburg F., Mellmann A., Peters G., Karch H. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob. Agents Chemother. 2012, 56:3277-3282.
13. Boehm A., Steiner S., Zaehringer F., Casanova A., Hamburger F., Ritz D., Keck W., Ackermann M., Schirmer T., Jenal U. Second messenger signalling governs Escherichia coli biofilm induction upon ribosomal stress. Mol. Microbiol. 2009, 72:1500-1516.
14. Boles B.R., Singh P.K. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc. Natl. Acad. Sci. USA 2008, 105:12503-12508.
15. Burmolle M., Thomsen T.R., Fazli M., Dige I., Christensen L., et al. Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. FEMS Immunol. Med. Microbiol. 2010, 59:324-336.
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement, 2010; M100-S20 and M100 S20 Supplement. Wayne, PA, EE.UU.
17. Croxen M.A., Law R.J., Scholz R., Keeney K.M., Wlodarska M., Finlay B.B. Recent advances in understanding enteric pathogenic Escherichia coli. Clin. Microbiol. Rev. 2013, 26:822-880.
18. Dwyer D.J., Kohanski M.A., Hayete B., Collins J.J. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 2007, 3:91.
19. Dwyer D.J., Kohanski M.A., Collins J.J. Role of reactive oxygen species in antibiotic action and resistance. Curr. Opin. Microbiol. 2009, 12:482-489.
20. Fernández D., Krüger A., Polifroni R., Bustamante V.A., Sanso M., Etcheverría A.I., Lucchesi P.M.A., Parma A.E., Padola N.L. Characterization of Shiga toxin producing Escherichia coli O130:H11 and O178:H19 isolated from dairy cows. Front. Cell. Infect. Microbiol. 2013, 8:3-9.
21. Goswami M., Mangoli S.H., Jawali N. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob. Agents Chemother. 2006, 50:949-954.
22. Hoffman L.R., D'Argenio D.A., MacCoss M.J., Zhang Z., Jones R.A., Miller S.I. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005, 436:1171-1175.
23. Kim Y.H., Lee Y., Kim S., Yeom J., Seok Kim B., Oh S., Park S., Jeon C.O., Park W. The role of periplasmic antioxidant enzymes of the Shiga toxin-producing E. coli O157:H7 in the formation of biofilms. Proteomics 2006, 23:6181-6193.
24. Kimmitt P.T., Harwood C.R., Barer M.R. Toxin gene expression by Shiga toxin producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg. Infect. Dis. 2000, 6:458-465.
25. Kohanski M.A., Dwyer D.J., Hayete B., Lawrence C.A., Collins J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130:797-810.
26. Kohanski M.A., Dwyer D.J., Wierzbowski J., Cottarel G., Collins J.J. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 2008, 135:679-690.
27. Kolodkin-Gal I., Engelberg-Kulka H. The extracellular death factor: physiological and genetic factors influencing its production and response in Escherichia coli. J. Bacteriol. 2008, 190:3169-3175.
28. Kolodkin-Gal I., Sat B., Keshet A., Kulka H.E. The communication factor EDF and the toxin-antitoxin module mazEF determine the mode of action of antibiotics. PLoS Biol. 2008, 6:2775-2785.
29. Kothary V., Scherl E.J., Bosworth B., Jiang Z.D., Dupont H.L., Harel J., Simpson K.W., Dogan B. Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β naphthylamide-inhibitable efflux pumps. Antimicrob. Agents Chemother. 2013, 57:811-817.
30. Krüger A., Lucchesi P.M.A., Parma Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity. Appl. Environ. Microbiol. 2011, 77:73-79.
31. Kuczynska-Wisnik D., Matuszewska E., Laskowska E. Escherichia coli heat-shock proteins IbpA and IbpB affect biofilm formation by influencing the level of extracellular indole. Microbiology 2010, 156:148-157.
32. Landoni V.I., de Campos-Nebel M., Schierloh P., Calatayud C., Fernandez G.C., Ramos M.V., Rearte B., Palermo M.S., Isturiz M.A. Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha. Infect. Immun. 2010, 78:1193-1201.
33. Ledesma M.A., Ochoa S.A., Cruz A., Rocha-Ramírez L.M., Mas-Oliva J., Eslava C.A., Xicohtencatl-Cortes J. The hemorrhagic coli pilus (HCP) of Escherichia coli O157:H7 is an inducer of proinflammatory cytokine secretion in intestinal epithelial cells. PLoS ONE 2010, 5:e12127.
34. Lee J.H., Stein B.D. Antimicrobials effective for inhibition of enterohaemorrhagic Escherichia coli strains O26, O111, and O157 and their effects on Shiga toxin releases. J. Microbiol. Biotechnol. 2009, 19:1238-1243.
35. Loś J.M., Loś M., Wegrzyn A., Wegrzyn G. Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157:H7. FEMS Immunol. Med. Microbiol. 2010, 58:322-329.
36. McGannon C.M., Fuller C.A., Weiss A.A. Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob. Agents Chemother. 2010, 54:3790-3798.
37. Nataro J.P. Enteroaggregative Escherichia coli pathogenesis. Curr. Opin. Gastroenterol. 2005, 21:4-8.
38. Nguyen Y., Sperandio V. Enterohemorrhagic E. coli (EHEC) pathogenesis. Front. Cell. Infect. Microbiol. 2012, 12:2-90.
39. Nguyen D., Joshi-Datar A., Lepine F., Bauerle E., Olakanmi O., et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011, 334:982-986.
40. O'Toole G.A., Kolter R. Initiation of biofilm formation in Pseudomonas fluorescensWCS365 proceeds via multiple, convergent signaling pathways: a genetic analysis. Mol. Microbiol. 1998, 28:449-461.
41. Ochoa T.J., Chen J., Walker C.M., Gonzales E., Cleary T.G. Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli. Antimicrob. Agents Chemother. 2007, 51:2837-2841.
42. Padayatty S.J., Katz A., Wang Y., Eck P., Kwon O., Lee J.H., Chen S., Corpe C., Dutta A., Dutta S.K., Levine M. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J. Am. Coll. Nutr. 2003, 22:18-35.
43. Páez P.L., Becerra M.C., Albesa I. Antioxidative mechanisms protect resistant strains of Staphylococcus aureus against ciprofloxacin oxidative damage. Fundam. Clin. Pharmacol. 2010, 24:771-776.
44. Páez P.L., Becerra M.C., Albesa I. Effect of the association of reduced glutathione and ciprofloxacin on the antimicrobial activity in Staphylococcus aureus. FEMS Microbiol. Lett. 2010, 303:101-105.
45. Páez P.L., Becerra M.C., Albesa I. Comparison of macromolecular oxidation by reactive oxygen species in three bacterial genera exposed to different antibiotics. Cell Biochem. Biophys. 2011, 61:467-472.
46. Páez P.L., Becerra M.C., Albesa I. Impact of ciprofloxacin and chloramphenicol on the lipid bilayer of Staphylococcus aureus: changes in membrane potential. Biomed. Res. Int. 2013, 2013:276524.
47. Paraje M.G. Antimicrobial resistance in biofilms. Science Against Microbial Pathogens: Communicating Current Research and Technological Advances 2011, Formatex Research Center, Badajoz, pp. 736-744. A. Méndez-Vilas (Ed.).
48. Paton A.W., Paton J.C. Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J. Clin. Microbiol. 2002, 40:271-274.
49. Rivas L., Dykes G.A., Fegan N. A comparative study of biofilm formation by Shiga toxigenic Escherichia coli using epifluorescence microscopy on stainless steel and a microtitre plate method. J. Microbiol. Methods 2007, 69:44-51.
50. Ryu J.H., Beuchat L.R. Biofilm formation by Escherichia coli O157:H7 on stainless steel: effect of exopolysaccharide and curli production on its resistance to chlorine. Appl. Environ. Microbiol. 2005, 71:247-255.
51. Ryu J.H., Kim H., Beuchat L.R. Attachment and biofilm formation by Escherichia coli O157:H7 on stainless steel as influenced by exopolysaccharide production, nutrient availability, and temperature. J. Food Prot. 2004, 10:2123-2131.
52. Schlag S., Nerz C., Birkenstock T.A., Altenberend F., Götz F. Inhibition of staphylococcal biofilm formation by nitrite. J. Bacteriol. 2007, 189:7911-7919.
53. Smith K.E., Wilker P.R., Reiter P.L., Hedican E.B., Bender J.B., Hedberg C.W. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr. Infect. Dis. J. 2012, 31:37-41.
54. Tarr P.I., Gordon C.A., Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365:1073-1086.
55. Teel L.D., Daly J.A., Jerris R.C., Maul D., Svanas G., O'Brien A.D., Park C.H. Rapid detection of Shiga toxin-producing Escherichia coli by optical immunoassay. J. Clin. Microbiol. 2007, 45:3377-3380.
56. Ullrich S., Bremer P., Neumann-Grutzeck C., Otto H., Rüther C., von Seydewitz C.U., Meyer G.P., Ahmadi-Simab K., Röther J., Hogan B., Schwenk W., Fischbach R., Caselitz J., Puttfarcken J., Huggett S., Tiedeken P., Pober J., Kirkiles-Smith N.C., Hagenmüller F. Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center study. PLoS ONE 2013, 8:55278.
57. Van Meervenne E., De Weirdt R., Van Coillie E., Devlieghere F., Herman L., Boon N. Biofilm models for the food industry: hot spots for plasmid transfer?. Pathog. Dis. 2014, 70:332-338.
58. Zhang X., McDaniel A.D., Wolf L.E., Keusch G.T., Waldor M.K., Acheson D.W. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 2000, 181:664-670.
59. Zhang Q., Donohue-Rolfe A., Krautz-Peterson G., Sevo M., Parry N., Abeijon C., Tzipori S. Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection. J. Infect. Dis. 2009, 199:486-493.